Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Avivagen Secures Approval for Use of OxC-beta(TM) Livestock in Brazil and Signs Distribution Agreement

Business Wire June 24, 2020

Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2020

Business Wire June 2, 2020

Avivagen Announces Increase in North American OxC-beta(TM) Livestock Order Following Successful Dairy Field Tests

Business Wire May 20, 2020

Avivagen Secures Largest-Yet Order of OxC-beta(TM) Livestock

Business Wire April 7, 2020

Avivagen Inc. to Issue Shares to Holders of Debentures in Lieu of Annual Maintenance Fee

Business Wire April 2, 2020

Avivagen Secures New Sales of OxC-beta(TM) in Taiwan and Thailand

Business Wire April 2, 2020

Avivagen Announces First Purchase Orders of OxC-beta(TM) Livestock in Mexico

Business Wire March 25, 2020

Avivagen Inc. to Issue Shares in lieu of Annual Maintenance Fee

Business Wire March 23, 2020

Avivagen Accelerates Plans for Commercial Launch of Its OxC-Beta(TM) Technology for Human Use in Response to COVID-19 Pandemic

Business Wire March 17, 2020

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

Business Wire March 10, 2020

Avivagen Inc. Announces Stock Option Grants

Business Wire March 6, 2020

Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2020

Business Wire March 4, 2020

Avivagen Announces Positive Results from New Zealand OxC-beta(TM) Livestock Dairy Trial for Use Against Sub-Clinical Mastitis

Business Wire February 24, 2020

Avivagen Finalizes Distribution Agreement with INPHILCO in the Philippines

Business Wire February 18, 2020

Avivagen Announces CEO Update to Shareholders

Business Wire January 29, 2020

Avivagen Announces Closing of Additional $1.75 Million Private Placement

Business Wire January 27, 2020

Mimi's Rock Corp. and Avivagen Inc. Announce Launch of Dr Tobias Dog Chews on Amazon.com

Canada NewsWire January 23, 2020

Avivagen Announces Update on Private Placement Process

Business Wire January 20, 2020

Avivagen Inc. Commences Trading on the OTCQB® Venture Market in the U.S.

Business Wire January 8, 2020

Avivagen Announces Closing of $1.25 Million Private Placement

Business Wire January 3, 2020